{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T13:57:28Z","timestamp":1700056648089},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/wnf.0b013e3180cfe3a0","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T06:43:33Z","timestamp":1613025813000},"page":"245-246","source":"Crossref","is-referenced-by-count":5,"title":["Neuroleptic Malignant Syndrome Due to Amisulpride in a Patient With Solvent-Induced Chronic Toxic Encephalopathy"],"prefix":"10.1097","volume":"30","author":[{"given":"Vaios","family":"Peritogiannis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Tsouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venetsanos","family":"Mavreas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spiros","family":"Konitsiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome.","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4088\/JCP.v65n1219f","article-title":"Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.","volume":"65","author":"Atbasoglu","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs.","volume":"65","author":"Ananth","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s004200000119","article-title":"Criteria for solvent-induced chronic toxic encephalopathy: a systematic review.","volume":"73","author":"van der Hoek","year":"2000","journal-title":"Int Arch Occup Environ Health"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(96)07218-2","article-title":"Solvents and neurotoxicity.","volume":"349","author":"White","year":"1997","journal-title":"Lancet"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v64n0918","article-title":"The use of atypical antipsychotics in nursing homes.","volume":"64","author":"Liperoti","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases.","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DBL Consortium.","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"R9-9-20210203","first-page":"2323","article-title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.","volume":"34","author":"Black","year":"2003","journal-title":"Sroke"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease.","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/alcalc\/36.6.553","article-title":"A case of Korsakoff's syndrome improved by high doses of donepezil.","volume":"36","author":"Iga","year":"2001","journal-title":"Alc Alcoholism"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0149-2918(04)90172-5","article-title":"Effects of rivastigmine on behavioral and psychological symptoms of in Alzheimer's disease.","volume":"26","author":"Finkel","year":"2004","journal-title":"Clin Ther"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145703003857","article-title":"Neuroleptic malignant syndrome induced by donepezil letter.","volume":"7","author":"Matsumoto","year":"2004","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002826-200707000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T06:43:41Z","timestamp":1613025821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-200707000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3180cfe3a0","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}